- Email: [email protected]
Ceco sees revenues rise with acquisition
October I999
Filtration lndustry Analyst
WHATMAN CONTINUES ON ACQUSITION PATH Specialist separations technology company Whatman plc has made an offer to acquire the entire share capital and convertible loan stock of DNA purification business Cambridge Molecular Technologies Ltd for approximately 24 million in cash. The board of Cambridge Molecular is recommending acceptance of the offer and irrevocable acceptances have .been received by Whatman in respect of 64% of the ordinary share capital, 79% of the preference share capital and 97% of the nominal value of the loan stock. Cambridge Molecular has developed a contract service supplying purified DNA for the pharmaceutical and biotechnology sectors predominately for use in pharmacogenomics studies requiring genetic profiling. Whaiman plans to use its 1998 acquisition of Fitzco Inc, which has exclusive global rights to a technique for storing DNA on paper, to improve the product range and service element of Cambridge Molecular.
PUROLATOR UNVEILS AUTO FILTER WEBSITE , Purolator Products, a division of Arvin Industries Inc, has introduced the first automotive filter website to have a working e-catalogue that contains both a cross reference and a passenger car and light truck applications look-up. The e-catalogue includes over 18 000 automotive passenger and light truck listings covering the years 1942-1999, and over 89 000 original equipment manufacturers cross reference part numbers with a total of 92 different manufacturers. The catalogue can be i found at www.pureoil.com.
VIVENDI
BOOSTS
ITS US POSITION Strengthening its standing in municipal and industrial water treatment markets, ~. Vivendi Water has combined the operations of the North American water industry’s two largest outsourcing companies: USFilter’s Operating Services and G6n6rale des Eaux’s Professional Services Group (PSG). The new body will be marketed under the USFilter Operating Services banner as the continent’s largest and fastest growing water and wastewater treatment, outsourcing and public/private partnership company. With the acquisition of USFilter in April of this year (see
Filtmtim
Industry
Ann-
!\.s/, April 1999), Vivendi’s subsidiaries, including Gin&ale des Eaux. now account for 8.9% of the global desalination market - a share the company says is the largest in the industry.
GL&V CLOSES DORR-OLIVER DEAL Groupe Laperriere & Verreault Inc (CL&V) has closed the largest acquisition in its history by purchasing all the shares of the Dorr-Oliver group of companies, a leading technological solutions provider for liquid-solid separation. This is a move CL&V says will add around US$lOO million in hales (see Filtvtrtiori Industq~ Anulwt. August 1999). In addition to boosting GL&V’s annual sales to over US$300 million the integration plan for Dorr-Oliver also provides the company with potential synergetic savings of around US%12 million per year. GL&V’s president Laurent Verreault says that the company will merge some of Dorr-Oliver’s sales offices
/ with those of GL&V in order to benefit from the strengths of i both oreanisations, building on their complementary activities. Given the size of the acquisition GL&V is giving itself a year in which to complete the integration. With the September 1998 acquisition of Cellco and now the Don--Oliver acquisition, GL&V’s operations will be balanced between two growth segments, one focusing on pulp and paper. which will account for around 50% of revenues, and the other on various target markets such as chemcals, mining and minerals, energy and the food industry. This will considerably reduce the dependence of the company on one market, especially as revenues will be spread around the world reduckng the risk of negative impacts from regional economic downturns.
CECO SEES REVENUES RISE WITH ACQUISITIONS Ceco Environmental Corp has signed a letter of intent to acquire air pollution control company Kirk & Blum Manufacturing Co and its associated company kbd/ Technic. The acquisition will be an all cash transaction and non dilutive to Ceco shareholders. Kirk & Blum and kbd/Technit’s combined 1998 revenues of US$7 I million will add significant earnings growth and new market opportunities to the consolidated businesses that will form Ceco. increasing the new company’s 2000 rcvenues to over USXIOO million. Ceco’s president. Phillip DeZwirek says that it’s US$ I5 per share offer for all the outstanding common shares of Peerless Manufacturing Co is still a business opportunity that Ceco will continue to pursue (see
F-iltrcltior7
Ittdust~
AITLI-
Editorial Office Elsevier Advanced Technology PO Box 150 Kidlington Oxford OX5 1AS United Kingdom Tel: +44 (0)1865 843676 Fax: +44 (0)1865 843971 E-mail: j.gilbyOelsevier.co.uk Editor Jane Gilby Progremme iditor Roisin Reidy Permissionsmaybe sought. directki:~s~~‘d~;~~ %%ct 600, Oxford OX5 1DX. lJi<; phone: (+44) 1865 643630, fax: (+44) 1865 853333, *mail: permissions @?elswier.co.uk. You may also contact Rights & Permissions directly through Elswier’s home page (http://www.elswier.nl), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permIssions and make ayfnenis through the Cop right lesrance Center, Inc., 222 L sewood 8 Drive, Danvers, MA 01923, USA: phone: (97E) 75084oo. fax: (978) 7504744, y&g gy$$y$ggJ Service (CLARCS), 90 Tottenhem Court Road, London WlP OLP, UK; phone: (+44) 171 436 5931; fax: (+44) 171436 3986. Other countries may have a locat reprographic rights agency for payments. Derivative Worlcs Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the mstitution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publsher is required to store or use electronically any material contained in this journal, including any article or part of an artide. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means. electronic. mechanical, photocopying, recording or otherwise, without prior wntten permission of the publisher. Address permissions requests to: Eisevier Science Rights & Permissions Department, at the mail, fax and e-mail addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negllgence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Iy.rt, September 1999).
02207 Printed
h) Magfield
Press. Oxon, UK.
Filtration lndustry Analyst
WHATMAN CONTINUES ON ACQUSITION PATH Specialist separations technology company Whatman plc has made an offer to acquire the entire share capital and convertible loan stock of DNA purification business Cambridge Molecular Technologies Ltd for approximately 24 million in cash. The board of Cambridge Molecular is recommending acceptance of the offer and irrevocable acceptances have .been received by Whatman in respect of 64% of the ordinary share capital, 79% of the preference share capital and 97% of the nominal value of the loan stock. Cambridge Molecular has developed a contract service supplying purified DNA for the pharmaceutical and biotechnology sectors predominately for use in pharmacogenomics studies requiring genetic profiling. Whaiman plans to use its 1998 acquisition of Fitzco Inc, which has exclusive global rights to a technique for storing DNA on paper, to improve the product range and service element of Cambridge Molecular.
PUROLATOR UNVEILS AUTO FILTER WEBSITE , Purolator Products, a division of Arvin Industries Inc, has introduced the first automotive filter website to have a working e-catalogue that contains both a cross reference and a passenger car and light truck applications look-up. The e-catalogue includes over 18 000 automotive passenger and light truck listings covering the years 1942-1999, and over 89 000 original equipment manufacturers cross reference part numbers with a total of 92 different manufacturers. The catalogue can be i found at www.pureoil.com.
VIVENDI
BOOSTS
ITS US POSITION Strengthening its standing in municipal and industrial water treatment markets, ~. Vivendi Water has combined the operations of the North American water industry’s two largest outsourcing companies: USFilter’s Operating Services and G6n6rale des Eaux’s Professional Services Group (PSG). The new body will be marketed under the USFilter Operating Services banner as the continent’s largest and fastest growing water and wastewater treatment, outsourcing and public/private partnership company. With the acquisition of USFilter in April of this year (see
Filtmtim
Industry
Ann-
!\.s/, April 1999), Vivendi’s subsidiaries, including Gin&ale des Eaux. now account for 8.9% of the global desalination market - a share the company says is the largest in the industry.
GL&V CLOSES DORR-OLIVER DEAL Groupe Laperriere & Verreault Inc (CL&V) has closed the largest acquisition in its history by purchasing all the shares of the Dorr-Oliver group of companies, a leading technological solutions provider for liquid-solid separation. This is a move CL&V says will add around US$lOO million in hales (see Filtvtrtiori Industq~ Anulwt. August 1999). In addition to boosting GL&V’s annual sales to over US$300 million the integration plan for Dorr-Oliver also provides the company with potential synergetic savings of around US%12 million per year. GL&V’s president Laurent Verreault says that the company will merge some of Dorr-Oliver’s sales offices
/ with those of GL&V in order to benefit from the strengths of i both oreanisations, building on their complementary activities. Given the size of the acquisition GL&V is giving itself a year in which to complete the integration. With the September 1998 acquisition of Cellco and now the Don--Oliver acquisition, GL&V’s operations will be balanced between two growth segments, one focusing on pulp and paper. which will account for around 50% of revenues, and the other on various target markets such as chemcals, mining and minerals, energy and the food industry. This will considerably reduce the dependence of the company on one market, especially as revenues will be spread around the world reduckng the risk of negative impacts from regional economic downturns.
CECO SEES REVENUES RISE WITH ACQUISITIONS Ceco Environmental Corp has signed a letter of intent to acquire air pollution control company Kirk & Blum Manufacturing Co and its associated company kbd/ Technic. The acquisition will be an all cash transaction and non dilutive to Ceco shareholders. Kirk & Blum and kbd/Technit’s combined 1998 revenues of US$7 I million will add significant earnings growth and new market opportunities to the consolidated businesses that will form Ceco. increasing the new company’s 2000 rcvenues to over USXIOO million. Ceco’s president. Phillip DeZwirek says that it’s US$ I5 per share offer for all the outstanding common shares of Peerless Manufacturing Co is still a business opportunity that Ceco will continue to pursue (see
F-iltrcltior7
Ittdust~
AITLI-
Editorial Office Elsevier Advanced Technology PO Box 150 Kidlington Oxford OX5 1AS United Kingdom Tel: +44 (0)1865 843676 Fax: +44 (0)1865 843971 E-mail: j.gilbyOelsevier.co.uk Editor Jane Gilby Progremme iditor Roisin Reidy Permissionsmaybe sought. directki:~s~~‘d~;~~ %%ct 600, Oxford OX5 1DX. lJi<; phone: (+44) 1865 643630, fax: (+44) 1865 853333, *mail: permissions @?elswier.co.uk. You may also contact Rights & Permissions directly through Elswier’s home page (http://www.elswier.nl), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permIssions and make ayfnenis through the Cop right lesrance Center, Inc., 222 L sewood 8 Drive, Danvers, MA 01923, USA: phone: (97E) 75084oo. fax: (978) 7504744, y&g gy$$y$ggJ Service (CLARCS), 90 Tottenhem Court Road, London WlP OLP, UK; phone: (+44) 171 436 5931; fax: (+44) 171436 3986. Other countries may have a locat reprographic rights agency for payments. Derivative Worlcs Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the mstitution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publsher is required to store or use electronically any material contained in this journal, including any article or part of an artide. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means. electronic. mechanical, photocopying, recording or otherwise, without prior wntten permission of the publisher. Address permissions requests to: Eisevier Science Rights & Permissions Department, at the mail, fax and e-mail addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negllgence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Iy.rt, September 1999).
02207 Printed
h) Magfield
Press. Oxon, UK.